Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SUDEEPPHRM
₹1,123.85
₹1106.10
₹1137.75
₹524.05
₹1180.00
Markets Today
Historical Performance
As of 24-08-2026 11:57, Sudeep Pharma Ltd. share price today is ₹0, with a change of ₹-1111.80 (-100.00%) from the previous close of ₹1111.8. The stock opened at ₹1123.9 and traded between ₹1106.1 and ₹1137.75, with a total traded volume of 78946 shares. The company has a market capitalization of ₹13061.4 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1180 and ₹524.05, respectively.
Sudeep Pharma Ltd. valuation metrics include a P/E ratio of 71.5, EPS of ₹15.5, and book value of ₹14.80. Profitability indicators show ROE of 19.57% along with a dividend yield of 0.1%. Sudeep Pharma Ltd. has reported revenue of ₹675.61 Cr and net profit of ₹182.64 Cr.
Sudeep Pharma Ltd. technical indicators include Day RSI at 80.35, Day MFI at 82.02, Day ADX at 59.88. Additional indicators include Commodity Channel Index (CCI) at 107.3 and Williams %R at -0.81. Momentum indicators show Day MACD at 77.46, Day MACD Signal Line at 61.61, DayATR at 53.45. Rate of Change indicators for Sudeep Pharma Ltd. include ROC125 at 73.01 and ROC21 at 32.93.
Exponential moving averages include EMA5 at ₹1113.6, EMA10 at ₹1071.8, EMA12 at ₹1056.2, EMA20 at ₹1006.4, EMA26 at ₹978.7, EMA50 at ₹904.3, EMA100 at ₹819.2. Simple moving averages include SMA5 at ₹1113.7, SMA10 at ₹1076.6, SMA20 at ₹972, SMA30 at ₹931.1, SMA50 at ₹887.2, SMA100 at ₹777.6, SMA150 at ₹722.1.
Support levels for Sudeep Pharma are placed at First Support ₹1116.87, Second Support ₹1077.33, Third Support ₹1056.12. Resistance levels are seen at First Resistance ₹1177.62, Second Resistance ₹1198.83, Third Resistance ₹1238.37. Sudeep Pharma Ltd. shareholding pattern shows promoter holding at 76.15%, FII holding at 1.81%, DII holding at 0%, public holding at 6.39%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 105.68 | 80.17 | 90.28 | 87.88 | 80.17 |
| Operating Expense | 66.49 | 51.28 | 60.67 | 57 | 49.78 |
| Operating Profit | 39.19 | 28.89 | 29.61 | 30.88 | 30.39 |
| Depreciation | 1.83 | 1.79 | 1.79 | 1.77 | 1.75 |
| Interest | 1.76 | 1.97 | 0.63 | 2.03 | 1.44 |
| Tax | 11.58 | 8.98 | 9.76 | 10.16 | 8.62 |
| Net Profit | 33.83 | 25.77 | 26.87 | 29.74 | 25.20 |
₹1123.85
↗ Bullish Moving Average
14
↘ Bearish Moving Average
0
| Held By | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoter | 76.2 | 76.2 | 76.2 |
| FII | 1.7 | 1.6 | 1.8 |
| DII | 17.6 | 18.1 | 15.6 |
| Public | 4.6 | 4.2 | 6.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.64 L | 4.76 L | 55.55% |
| Week | 1.06 L | 2.12 L | 49.86% |
| 1 Month | 1.65 L | 4.09 L | 40.33% |
| 6 Month | 1.21 L | 2.5 L | 48.52% |
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
New 52 Week High
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 23 Jul, 2026 | 1.5 | FINAL | 23 Jul, 2026 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹2,155.60 | ₹1,536.20 | ₹843 | ₹803.80 | ₹1,346.60 |
| % Change | 0.61% | -2.23% | 3.21% | -0.20% | -0.32% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹1,108.39 | ₹1,969.05 | ₹872.55 | ₹2,590.40 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹275.37 | ₹213.15 | ₹198.37 | ₹603.02 |
| PE TTM | 65.20 | 60.30 | 35.50 | 32.00 | 27.90 |
| 1 Year Return | 99.76 | -3.6 | -2.17 | 16.32 | 41.48 |
| ROCE | 31.54 | 16.71 | 10.79 | - | - |
Cohance Lifesciences Ltd.
₹ 452.20
-2.33%
Eris Lifesciences Ltd.
₹ 1313.80
-1.08%
Syngene International Ltd.
₹ 401.30
-1.46%
Alembic Pharmaceuticals Ltd.
₹ 815.00
-0.82%
Sun Pharma Advanced Research Company Ltd.
₹ 197.07
+0.18%
Strides Pharma Science Ltd.
₹ 981.30
-0.50%
FDC Ltd.
₹ 348.40
-0.06%
Shilpa Medicare Ltd.
₹ 862.35
+5.82%
Jubilant Pharmova Ltd.
₹ 891.55
+1.27%
Natco Pharma Ltd.
₹ 885.00
+0.29%
Caplin Point Laboratories Ltd.
₹ 2500.00
-2.37%
Marksans Pharma Ltd.
₹ 322.60
+0.40%
Orchid Pharma Ltd.
₹ 1020.50
+1.84%
Viyash Scientific Ltd.
₹ 268.60
-2.66%
AstraZeneca Pharma India Ltd.
₹ 7265.00
-2.03%
Bliss GVS Pharma Ltd.
₹ 570.50
-1.49%
Sanofi India Ltd.
₹ 3315.00
-1.13%
Morepen Laboratories Ltd.
₹ 96.40
+0.41%
Procter & Gamble Health Ltd.
₹ 5869.00
+0.69%
Jeena Sikho Lifecare Ltd.
₹ 515.35
+1.98%
Senores Pharmaceuticals Ltd.
₹ 1587.30
+4.89%
OneSource Specialty Pharma Ltd.
₹ 1528.80
-0.40%
Sanofi Consumer Healthcare India Ltd.
₹ 4189.80
-0.77%
Akums Drugs & Pharmaceuticals Ltd.
₹ 771.40
+2.85%
Innova Captab Ltd.
₹ 1080.60
-0.73%
By signing up I certify terms, conditions & privacy policy